Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)
Andrea Pession, Fraia Melchionda, Claudia CastelliniOncologia Ematologia Pediatrica “Lalla Seràgnoli”, Clinica Pediatrica, Università degli Studi di Bologna, Bologna, ItalyAbstract: Along with hydration and urinary alkalinization, allopurinol...
Saved in:
Main Authors: | Andrea Pession, Fraia Melchionda, Claudia Castellini |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2008
|
Subjects: | |
Online Access: | https://doaj.org/article/c4b726773fb0479fa170b61d8acf5fbd |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Urate oxidase purification by salting-in crystallization: towards an alternative to chromatography.
by: Marion Giffard, et al.
Published: (2011) -
Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout
by: Philip K. Tan, et al.
Published: (2017) -
The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion
by: Kazi Mirajul Hoque, et al.
Published: (2020) -
Clinical characteristics of tumor lysis syndrome in childhood acute lymphoblastic leukemia
by: Yao Xue, et al.
Published: (2021) -
Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in mice
by: Maimaiti Yisireyili, et al.
Published: (2017)